IRIS
LIUZZI, Grazia Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.749
EU - Europa 1.413
AS - Asia 755
OC - Oceania 4
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.732
CN - Cina 538
SE - Svezia 378
UA - Ucraina 242
IT - Italia 228
SG - Singapore 190
DE - Germania 180
FI - Finlandia 128
FR - Francia 112
GB - Regno Unito 64
BE - Belgio 24
IE - Irlanda 21
CA - Canada 16
IN - India 14
IR - Iran 8
RU - Federazione Russa 8
CZ - Repubblica Ceca 7
NL - Olanda 6
AU - Australia 4
JP - Giappone 4
HU - Ungheria 2
LT - Lituania 2
PL - Polonia 2
PT - Portogallo 2
AT - Austria 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
PE - Perù 1
SI - Slovenia 1
Totale 7.924
Salva come PNG Salva come JPEG
Città #
Woodbridge 682
Fairfield 604
Chandler 603
Jacksonville 561
Houston 405
Ashburn 336
Ann Arbor 334
Nyköping 315
Wilmington 243
Seattle 239
Cambridge 227
Singapore 144
Lawrence 127
Roxbury 126
Nanjing 111
Marseille 97
Beijing 96
Boardman 84
Des Moines 79
Bari 70
New York 67
Inglewood 56
Princeton 39
Jiaxing 37
Shenyang 33
Nanchang 29
Brooklyn 26
Santa Clara 26
Hebei 25
San Diego 25
Brussels 24
Changsha 21
Dublin 21
Guangzhou 21
Shanghai 19
Leawood 16
Tianjin 16
Dearborn 15
Spongano 15
Los Angeles 14
Auburn Hills 13
Munich 13
Monmouth Junction 12
Falls Church 11
Wuhan 11
Augusta 9
Norwalk 9
Paris 9
Rome 9
London 8
Pune 8
Ardabil 7
Helsinki 7
Jinan 7
Kunming 7
Milan 7
Washington 7
Zhengzhou 7
Hefei 6
Indiana 6
San Mateo 6
Amsterdam 5
Brno 5
Giovinazzo 5
Romola 5
Scottsdale 5
Toronto 5
Adelfia 4
Edmonton 4
Kilburn 4
Mumbai 4
Ningbo 4
San Francisco 4
Taizhou 4
Brooks 3
Heze 3
Palermo 3
Siena 3
Taranto 3
Wuxi 3
Aversa 2
Civitanova Marche 2
Frankfurt am Main 2
Fuzhou 2
Gothenburg 2
Grafing 2
Grottaferrata 2
Lecce 2
Melbourne 2
Miskolc 2
Molfetta 2
Moscow 2
Olomouc 2
Prescot 2
Regensburg 2
Sydney 2
Torino 2
Triggiano 2
Turin 2
Yiwu 2
Totale 6.323
Salva come PNG Salva come JPEG
Nome #
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 113
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 111
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 109
A thermodynamic and structural study of myelin basic protein in lipid membrane models 103
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 102
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 102
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 99
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 98
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 98
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 96
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 93
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 93
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 93
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 92
Autoimmune Myelofibrosis: report of three cases and review of the literature 91
null 91
Identification of water-soluble proteases in myelin preparations 90
null 90
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 90
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 89
null 87
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 86
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 86
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 84
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 84
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 84
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 83
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 83
Crystals of P2 myelin protein in lipid-bound form 82
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 81
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 80
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 78
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 78
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 78
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 78
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 78
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 77
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 75
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 74
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 73
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 73
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 73
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 73
Purification of bovine P2 myelin protein with bound lipids 72
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 70
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 69
The different forms of PNS myelin P0 protein within and outside lipid rafts 67
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 67
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 65
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 65
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 64
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 64
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 64
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 63
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 62
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 62
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 62
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 61
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 61
Meccanismi di demielinizzazione in pazienti con neuroAIDS 60
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 59
Meccanismo molecolare di “Swelling” in astrociti in coltura 59
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 58
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 57
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 57
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 57
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 56
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 56
null 56
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 55
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 55
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 55
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 55
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 55
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 54
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 54
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 53
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 53
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV 52
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases 52
Demyelination and cerebral toxoplasmosis in HIV-infected patients 51
Matrix Metalloproteinases in CNS Inflammation. 51
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 51
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 50
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 49
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 49
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 49
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 49
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 49
Plant Lectins Regulate the Release of Matrix Metalloproteases in Rat Glial Cell Cultures 48
Extracting and purifying R-phycoerythrin from Mediterranean red algae Corallina elongata Ellis & Solander 47
null 47
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 46
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 45
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 45
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 45
Plant lectins regulate the release of gelatinases in rat glial cell cultures?? 43
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 42
Regolazione del rilascio di gelatinasi da parte di cellule gliali trattate con lectine vegetali 41
Plant lectins regulate the release of matrix metallo proteinases in rat glial cell cultures 41
Totale 6.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.072 0 0 0 0 179 89 189 127 208 100 151 29
2020/20211.066 117 43 116 30 131 36 103 67 112 154 121 36
2021/2022805 24 116 6 24 33 51 32 47 57 55 158 202
2022/20231.675 197 138 106 170 216 213 13 187 347 36 25 27
2023/2024551 44 97 23 120 46 118 7 6 6 14 10 60
2024/2025486 130 41 197 60 58 0 0 0 0 0 0 0
Totale 8.055